The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Genome-wide association studies in pharmacogenomics
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Mallal, S., Phillips, E., Carosi, G., Molina, J.-M., Workman, C., Tomažič, J., Jägel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706135 · Cited by 1,835
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,826
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
Simon, T., Verstuyft, C., Mary-Krause, M., Quteineh, L., Drouet, E., Méneveau, N., Steg, P. G., Ferrières, J., Danchin, N., & Becquemont, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808227 · Cited by 1,728
Shuldiner, A. R. (2009) · JAMA · doi:10.1001/jama.2009.1232 · Cited by 1,505
Mallal, S., Nolan, D., Witt, C., Masel, G., Martin, A., Moore, C., Sayer, D., Castley, A., Mamotte, C., Maxwell, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07873-x · Cited by 1,380
Genetic diagnosis by whole exome capture and massively parallel DNA sequencing
Choi, M., Scholl, U. I., Ji, W., Liu, T., Tikhonova, I. R., Zumbo, P., Nayir, A., Bakkaloğlu, A., Özen, S., Sanjad, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910672106 · Cited by 1,329
Collet, J.-P., Hulot, J.-S., Pena, A., Villard, E., Esteve, J.-B., Silvain, J., Payot, L., Brugier, D., Cayla, G., Beygui, F., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61845-0 · Cited by 967
The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.
de Morais, S. M., Wilkinson, G. R., Blaisdell, J., Nakamura, K., Meyer, U. A., & Goldstein, J. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40694-6 · Cited by 956
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
study, F. T. D., Daly, A. K., International SAE Consortium, Donaldson, P. T., Bhatnagar, P., Shen, Y., Pe'er, I., Floratos, A., Daly, M. J., Goldstein, D. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.379 · Cited by 944
Self-citationHulot, J.-S. (2006) · Blood · doi:10.1182/blood-2006-04-013052 · Cited by 931
Pharmacogenomics and Individualized Drug Therapy
Eichelbaum, M., Ingelman-Sundberg, M., & Evans, W. E. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104724 · Cited by 720
Takeuchi, F., McGinnis, R., Bourgeois, S., Barnes, C., Eriksson, N., Soranzo, N., Whittaker, P., Ranganath, V., Kumanduri, V., McLaren, W., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000433 · Cited by 632
Schroth, W. (2009) · JAMA · doi:10.1001/jama.2009.1420 · Cited by 531
CYP4F2 genetic variant alters required warfarin dose
Caldwell, M. D., Awad, T., Johnson, J. A., Gage, B. F., Falkowski, M., Gardina, P., Hubbard, J., Turpaz, Y., Langaee, T. Y., Eby, C., et al. (2008) · Blood · doi:10.1182/blood-2007-11-122010 · Cited by 521
The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
Voora, D., Shah, S. H., Spasojevic, I., Ali, S., Reed, C. R., Salisbury, B. A., & Ginsburg, G. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.053 · Cited by 502
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
Cooper, G. M., Johnson, J. A., Langaee, T. Y., Feng, H., Stanaway, I. B., Schwarz, U. I., Ritchie, M. D., Stein, C. M., Roden, D. M., Smith, J. D., et al. (2008) · Blood · doi:10.1182/blood-2008-01-134247 · Cited by 481
Kirchheiner, J., Brøsen, K., Dahl, M. L., Gram, L. F., Kasper, S., Roots, I., Sjöqvist, F., Spina, E., & Brockmöller, J. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00299.x · Cited by 422
Pharmacogenetics – five decades of therapeutic lessons from genetic diversity
Meyer, U. A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1428 · Cited by 420
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges
Wilke, R. A., Lin, D. W., Roden, D. M., Watkins, P. B., Flockhart, D., Zineh, I., Giacomini, K. M., & Krauss, R. M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2423 · Cited by 391
Kindmark, A., Jawaid, A., Harbron, C. G., Barratt, B. J., Bengtsson, O. F., Andersson, T. B., Carlsson, S., Cederbrant, K. E., Gibson, N. J., Armstrong, M., et al. (2008) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500458 · Cited by 367
Treviño, L. R., Shimasaki, N., Yang, W., Panetta, J. C., Cheng, C., Pei, D., Chan, D., Sparreboom, A., Giacomini, K. M., Pui, C.-H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.4156 · Cited by 349
Transporter Pharmacogenetics and Statin Toxicity
Niemi, M. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.197 · Cited by 330
CYP2D6 and tamoxifen: DNA matters in breast cancer
Hoskins, J. M., Carey, L. A., & McLeod, H. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2683 · Cited by 322
Ising, M., Lucae, S., Binder, E. B., Bettecken, T., Uhr, M., Ripke, S., Kohli, M. A., Hennings, J. M., Horstmann, S., Kloiber, S., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.95 · Cited by 306
A Genomewide Association Study of Citalopram Response in Major Depressive Disorder
Garriock, H. A., Kraft, J. B., Shyn, S. I., Peters, E. J., Yokoyama, J. S., Jenkins, G. D., Reinalda, M. S., Slager, S. L., McGrath, P. J., & Hamilton, S. P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.029 · Cited by 288
Pharmacogenomics: Challenges and Opportunities
Roden, D. M., Altman, R. B., Benowitz, N. L., Flockhart, D. A., Giacomini, K. M., Johnson, J. A., Krauss, R. M., McLeod, H. L., Ratain, M. J., Relling, M. V., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00007 · Cited by 282
Bisphosphonate Associated Osteonecrosis of the Jaw
KHAN, A. A., SÁNDOR, G. K. B., DORE, E., MORRISON, A. D., ALSAHLI, M., AMIN, F., PETERS, E., HANLEY, D. A., CHAUDRY, S. R., LENTLE, B., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080759 · Cited by 280
Paulussen, A. D. C., Gilissen, R. A. H. J., Armstrong, M., Doevendans, P. A., Verhasselt, P., Smeets, H. J. M., Schulze-Bahr, E., Haverkamp, W., Breithardt, G., Cohen, N., et al. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0522-z · Cited by 280
Sarasquete, M. E., García-Sanz, R., Marín, L., Alcoceba, M., Chillón, M. C., Balanzategui, A., Santamaria, C., Rosiñol, L., de la Rubia, J., Hernandez, M. T., et al. (2008) · Blood · doi:10.1182/blood-2008-04-147884 · Cited by 238
Cytochrome P450 2C8: Substrates, inhibitors, pharmacogenetics, and clinical relevance
TOTAH, R., & RETTIE, A. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.12.267 · Cited by 225
Yang, J. J. (2009) · JAMA · doi:10.1001/jama.2009.7 · Cited by 216
Characterization of drug-specific T cells in lamotrigine hypersensitivity
Naisbitt, D. J., Farrell, J., Wong, G., Depta, J. P. H., Dodd, C. C., Hopkins, J. E., Gibney, C. A., Chadwick, D. W., Pichler, W. J., Pirmohamed, M., et al. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1507 · Cited by 211
Liu, C., Batliwalla, F., Li, W., Lee, A., Roubenoff, R., Beckman, E., Khalili, H., Damle, A., Kern, M., Furie, R., et al. (2008) · Molecular Medicine · doi:10.2119/2008-00056.liu · Cited by 208
Byun, E., Caillier, S. J., Montalban, X., Villoslada, P., Fernández, O., Brassat, D., Comabella, M., Wang, J., Barcellos, L. F., Baranzini, S. E., et al. (2008) · Archives of Neurology · doi:10.1001/archneurol.2008.47 · Cited by 174
A genome-wide association study of acenocoumarol maintenance dosage
Teichert, M., Eijgelsheim, M., Rivadeneira, F., Uitterlinden, A. G., van Schaik, R. H. N., Albert Hofman, D., Smet, P. A. G. M. D., van Gelder, T., Visser, L. E., & Stricker, B. H. C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp309 · Cited by 158
Lavedan, C. N., Licamele, L., Volpi, S., Hamilton, J., Heaton, C., Mack, K., Lannan, R., Thompson, A. D., Wolfgang, C. D., & Polymeropoulos, M. H. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.56 · Cited by 157
Cytochrome P450 epoxygenases as EDHF synthase(s)
Fleming, I. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.11.016 · Cited by 145
Turner, S. T., Bailey, K. R., Fridley, B. L., Chapman, A. B., Schwartz, G. L., Chai, H. S., Sicotte, H., Kocher, J., Rodin, A. S., & Boerwinkle, E. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.104273 · Cited by 115
Volpi, S., Heaton, C., Mack, K., Hamilton, J., Lannan, R., Wolfgang, C. D., Licamele, L., Polymeropoulos, M. H., & Lavedan, C. N. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.52 · Cited by 110
Mick, E., Neale, B., Middleton, F. A., McGough, J. J., & Faraone, S. V. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30865 · Cited by 108
Clinical and pharmacogenetic factors associated with irinotecan toxicity
Kweekel, D. M., Guchelaar, H., & Gelderblom, H. A. J. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.05.002 · Cited by 100
Inada, T., Koga, M., Ishiguro, H., Horiuchi, Y., Syu, A., Yoshio, T., Takahashi, N., Ozaki, N., & Arinami, T. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f70492 · Cited by 97
Pharmacogenomics of Adverse Drug Reactions: Practical Applications and Perspectives
Becquemont, L. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.37 · Cited by 96
Emerging DNA sequencing technologies for human genomic medicine
Strausberg, R. L., Levy, S., & Rogers, Y.-H. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.03.025 · Cited by 62
Zhang, J. E., Jorgensen, A., Alfirevic, A., Williamson, P. R., Toh, C. H., Park, B. K., & Pirmohamed, M. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283311347 · Cited by 53
Pharmacogenetics-Guided Dose Modifications of Antidepressants
Seeringer, A., & Kirchheiner, J. (2008) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2008.05.006 · Cited by 49
Pharmacogenomics of anticoagulants: steps toward personal dosage
Daly, A. K. (2009) · Genome Medicine · doi:10.1186/gm10 · Cited by 49
Self-citation
Cited by
Genomics is failing on diversity
Popejoy, A. B., & Fullerton, S. M. (2016) · Nature · doi:10.1038/538161a · Cited by 1,924
The impact of next-generation sequencing on genomics
Zhang, J., Chiodini, R., Badr, A., & Zhang, G. (2011) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2011.02.003 · Cited by 577
“Although several early GWAS studies reported potentially promising results, the majority of GWAS studies were disappointing because of inadequate sample size, limitation of arrays for certain genetic variations, and/or heterogeneity in phenotype (Daly, 2010a).”
BackgroundManchia, M., Adli, M., Akula, N., Ardau, R., Aubry, J.-M., Backlund, L., Banzato, C. E., Baune, B. T., Bellivier, F., Bengesser, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065636 · Cited by 417
Tamba, C. L., Ni, Y.-L., & Zhang, Y.-M. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005357 · Cited by 286
Genetics of primary sclerosing cholangitis and pathophysiological implications
Jiang, X., & Karlsen, T. H. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.154 · Cited by 155
Metadata
- Authors
- Daly, A. K.
- Venue
- Nature Reviews Genetics
- Published
- 2010-04
- Volume
- 11
- Issue
- 4
- Pages
- 241-246
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W2090663229
- Cited by
- 264
- References
- 51
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.